Cost-Cutting Plus Value-Add Defines Quality's Role in a Recession
CHAPEL HILL, N.C., April 23 /PRNewswire/ -- Pharmaceutical and biotech partners tasked with cutting costs and improving processes cross-functionally recently asked us: What are the implications of the current economic situation on quality groups? How can I harness the kn...Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients
DEERFIELD, Ill. and SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO ) today announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the E...Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
The first hemostasis kit combines two important surgical tools: Baxter's human thrombin and Pfizer's GELFOAM DEERFIELD, Ill., Dec. 17 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced the Food and Drug Administration approval of GELFOAM(R) Plus Hemostasis...Sunrise Biotech Holding Limited Application For Admission to PLUS
BEIJING, Nov. 14 /Xinhua-PRNewswire/ -- The directors of Sunrise Biotech Holding Limited ("Sunrise" or the "Company"), a leading producer of organic mulberry-based products in China, are pleased to announce the Company has applied for the admission of its entire ordinary share capital for trad...Physicians Plus to make alternative drug info available online
Madison, Wis. Physicians Plus , an HMO in south-central Wisconsin with about 100,000 members, has purchased a web-based system from RxEOB , in Richmond, Virginia, to provide benefits information to consumers. Physicians Plus members will be able to access their personal pharmacy claims hist...Sensitivity and Quantitation using a Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer
Gargi Choudhary, Tania A. Sasaki, and Julian J. Phillips, Thermo Electron Corporation, San Jose, CA Chromatography and Mass Spectrometry Application Report Introduction Ion trap mass spectrometry is widely recognized for solving analytical problems requi...Calcium Plus Assay Kit, Superior Detection for Specialized Targets
HOMOGENEOUS ASSAY HIGHER MAXIMUM SIGNAL RAPID PROCEDURE COMPATIBLE WITH MORE TARGETS SUITABLE FOR HTS APPLICATONS The Calcium Plus Assay Kit provides a reliable and homogeneous method for detec...Using the SpectraMax Plus for USP Dissolution Calibration (MaxLine Application Note #27)
INTRODUCTION Calibration of a dissolution apparatus is necessary to produce accurate results for dissolution testing of pharmaceutical dosage forms and to allow comparison between batches and between laboratories. USP requirements for calibration are given in the Appa...Cell Proliferation Assay Using the Benchmark Plus Microplate Spectrophotometer
William C Heiser, PhD and Ma Theresa Redila-Flores, Bio-Rad Laboratories, Inc . , Hercules, CA 94547 USA Introduction An accurate and rapid assessment of viable cell number and proliferation is often required for in vitro and i...Benchmark Plus Microplate Reader Scan Well Feature
Theresa Redila-Flores and Li Tian, PhD, Bio-Rad Laboratories, 2000 Alfred Nobel Drive, Hercules, CA 94547 USA The Benchmark Plus microplate reader is a new monochromator- based absorbance reader from Bio-Rad that offers superior convenience,...Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A
Peter M Kilby, Roche Discovery Welwyn, 40 Broadwater Road, Welwyn Garden City, Herts, AL7 3AY, UK. Current Address: Analytical Sciences, Syngenta, Jealotts Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK Ab...Novavax Reports Second Quarter 2009 Financial Results
...notes in April 2009 by paying 70% of the principal plus accrued and unpaid interest, or $12.1 million, in ...s, the company elected to pay 50% of the principal plus accrued and unpaid interest, or $2.6 million, in c...to pay the remaining $2.6 million of the principal plus accrued and unpaid interest. Entered into ...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
...ng q12h and q8h cohorts, respectively. There was no evidence of viral rebound during ITMN-191 treatment in any cohort. ITMN-191 plus standard-of-care therapy was safe and generally well tolerated. Also at the EASL meeting in late April, InterMune, Roche and Pharm...OncoGenex Reports Second Quarter 2009 Financial Results
...pared to docetaxel alone. The median overall survival in patients with advanced metastatic prostate cancer who were treated with OGX-011 plus docetaxel in a randomized phase 2 trial was 23.8 months compared to 16.9 months for patients treated with docetaxel alone -- a 6.9 month...Pharmasset to Present at Canaccord Adams Conference
...nical-stage product candidates: RG7128, a nucleoside analog for chronic HCV infections, is in a Phase 2b clinical trial in combination with Pegasys(R) plus Copegus(R) and is also in INFORM studies, the first series of studies designed to assess the potential of combinations of small molecules without Pega...ETC Biomedical Announces Chamber Sale in India
...m. The BARA-MED(R) XD includes O.S.C.A.R. (TM) (Operating System for Control And Recordkeeping), giving you the benefit of patient comfort and safety, plus electronic medical recordkeeping (EMR). With O.S.C.A.R. (TM) on your team, you eliminate the need for operator dive time management and paper r...Biotech Hot in July Driven by Positive Drug Data and Acquisitions
...gainst the inflammatory disease for over 50 years. Patients taking Benlysta plus a standard treatment for one year had reduced symptoms - including pain, rashes and infections - compared with patients taking standard treatment plus placebo. The study involved more than 860 patients in Asia, South America a...Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
... CE MARK in 2006 and there have been over 50 clinical cases completed to date outside of the U.S. "The early clinical results achieved with TMR plus biologics suggest the potential of this combination therapy; to not only mitigate the debilitating effects of refractory angina, but potentially to im...Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
...nterest rates. EBITDA, which is defined as net income (loss) (excluding the non-controlling interest and income from equity method investees) plus income taxes, interest expense, depreciation and amortization, was $299.1 million for the quarter ended June 30, 2009 and $625.8 million for the six m...Schering-Plough Reports Financial Results for 2009 Second Quarter
...ich include sales of the cholesterol joint venture plus sales recorded by Schering-Plough in non-joint ven...ures Adjusted net sales, defined as Net sales plus an assumed 50 percent of global cholesterol jo... NOTE: Adjusted net sales, defined as net sales plus an assumed 50 percent of global cholesterol jo...Novavax Announces Repayment of $5 Million of Convertible Debt
...isfying certain conditions. Novavax has elected to pay 50% of the principal plus accrued and unpaid interest in cash for a total payment of approximately $2...ion and issued common stock for the remaining $2.6 million of the principal plus accrued and unpaid interest due by dividing that principal amount by $2.516...DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology
...lif., July 15 /PRNewswire/ -- DermTech, Inc., a biotechnology company developing non-invasive molecular diagnostics for the early detection of disease plus additional applications, announced that it has entered into the second part of a feasibility study using DermTech's advanced EGIR(TM) technology to he...Instrumentation Laboratory to Announce 'Passion & Results' Award Winners
...ort and energy and were chosen by the " IL eader Panel" to receive an award plus a $2,000 educational grant for their institution in recognition of their 'p...elligent Quality Management (iQM(R)), GEM Premier(TM) 4000 analyzer, GEMweb plus information management system, and the GEM PCL Plus, a portable coagulation...Researchers unite to distribute quantum keys
...tribution, QKD, network). Undertaken in late 2008, using the company internal glass fibre ring of Siemens and 4 of its dependencies across Vienna plus a repeater station, near St. Plten in Lower Austria, the QKD demonstration involved secure telephone communication and video-conference as well as a r...